Back to News
Market Impact: 0.35

Buy the dip on this drone stock set for big gains ahead, says Raymond James

AVAV
TGT
Company FundamentalsAnalyst InsightsCorporate Guidance & OutlookMarket Technicals & FlowsInfrastructure & Defense
Buy the dip on this drone stock set for big gains ahead, says Raymond James

Raymond James upgraded AeroVironment to Outperform and set a $210 12-month price target, implying ~49% upside from Wednesday’s close. The note cites a strong recent order flow, improving backlog quality, and accelerating product momentum, despite the stock being down ~45% over the past 12 months due to a late-2025 government shutdown that cut fiscal 2026 guidance and a March loss of a key U.S. Space Force contract. Offsetting positives include Army negotiations for its Enduring High Energy Laser program potentially worth ~$500M and a similar-sized domestic security contract, with Gesuale projecting the order book could grow ~20% QoQ and support revenue growth, expanding margins, and higher cash generation.

Analysis

AVAV is acting less like a pure drone OEM and more like a leveraged call option on U.S. defense budget reallocation toward autonomy, counter-UAS, and directed-energy systems. The important mechanism is not the headline order flow itself; it is that a cleaner mix of funded programs can reduce the discount investors apply to a historically lumpy revenue base and convert the stock from a “project risk” story into a “deployment rate” story. If the Army engagement converts, the market will likely reward that as evidence AVAV can win in areas with faster procurement cycles than traditional platform programs.

The second-order winner is likely AVAV’s ecosystem: electronics, optics, and niche manufacturing suppliers could see more stable demand if backlog quality improves, while larger primes may face pressure if AVAV is proven as the preferred specialist for swarm defense and high-energy laser niches. That said, consensus is already leaning positive, so near-term upside is probably more about multiple expansion than estimate revisions. The stock could rerate quickly on contract confirmation, but absent that, the move risks becoming a crowded “upgrade plus short-covering” trade rather than a durable fundamental change.

Risk is still budget timing and execution. A new shutdown, a delayed award, or another program loss would hit sentiment hard because the market is now paying for cleaner visibility. Over 6-18 months, the key falsifier is whether management can turn quoted opportunities into margin-accretive revenue; if revenue grows without cash conversion, the bull case weakens. The best contrarian read is that the stock may still be under-owned relative to its strategic relevance, but the path higher likely requires proof, not just narrative.